Effectiveness of Persian herbal formulation on migraine associated with functional dyspepsia

Investigating migraine from the perspective of Persian traditional medicine and the effectiveness of Persian herbal formulation on migraine associated with functional dyspepsia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170317033107N3

Enrollment

Registered

2020-01-11

Start date

2017-05-22

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine associated with functional dyspepsia. Migraine without aura [common migraine], Migraine with aura [classical migraine] Migraine: aura without headache basilar equivalents familial hemiplegic with: acute-onset aura prolonge

Interventions

Intervention 1: Intervention group 1": Three capsules of 750 mg of Persian Traditional Medicine Product (Contains Ginger, Amelah, Rose, Coriander) three times a day plus Depakin (Sanofi pharmaceutica

Eligibility

Sex/Gender

All

Age

17 Years to 55 Years

Inclusion criteria

Inclusion criteria: Migraine headache concurrently with functional dyspepsia Migraine headache criteria based on the latest version and presentation of dyspepsia

Exclusion criteria

Exclusion criteria: Headache with non diagnosis of migraine Stomach disorder with non diagnosis of functional dyspepsia

Design outcomes

Primary

Measure	Time frame
Headache frequency. Timepoint: Baseline and after 4, 8 and12 weeks of intervention. Method of measurement: Number of episodes in month.;Headache duration. Timepoint: Baseline and after 4, 8 and12 weeks of intervention. Method of measurement: Duration of each episode (in hour).;Headache severity. Timepoint: Baseline and after 4, 8 and12 weeks of intervention. Method of measurement: Visual Analog Scale.;Severity of functional dyspepsia. Timepoint: Baseline and 12 weeks after the intervention. Method of measurement: Parkman's criteria.	—

Measure

Time frame

Headache frequency. Timepoint: Baseline and after 4, 8 and12 weeks of intervention. Method of measurement: Number of episodes in month.;Headache duration. Timepoint: Baseline and after 4, 8 and12 weeks of intervention. Method of measurement: Duration of each episode (in hour).;Headache severity. Timepoint: Baseline and after 4, 8 and12 weeks of intervention. Method of measurement: Visual Analog Scale.;Severity of functional dyspepsia. Timepoint: Baseline and 12 weeks after the intervention. Method of measurement: Parkman's criteria.

—

Secondary

Measure	Time frame
Effect of headache on quality of life. Timepoint: Baseline and 12 weeks after intervention. Method of measurement: HIT-6 questionaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Gholampour

Mashhad University of Medical Sciences

Gholampoura1@mums.ac.ir+98 51 3884 8930

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026